Logo Logo
Switch Language to German
Satanovskij, Robin; Bader, Alhaddad; Block, Matthias; Herbst, Victor; Schlumberger, Wolfgang; Haack, Tobias; Nockher, Wolfgang Andreas; Heemann, Uwe; Renders, Lutz; Schmaderer, Christoph; Angermann, Susanne; Wen, Ming; Meitinger, Thomas; Scherberich, Jürgen; Steubl, Dominik (2017): A new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations - A tool for the diagnosis of uromodulin-associated kidney disease. In: Clinical Biochemistry, Vol. 50, No. 3: pp. 155-158
Full text not available from 'Open Access LMU'.


Background: Uromodulin-associated Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD-UMOD) belongs to a group of autosomal dominant inherited diseases caused by mutations in the UMOD gene, which codes for uromodulin, a protein exclusively expressed in renal tubular cells of the ascending limb of the loop of Henle. The diagnosis is hampered by non-specific clinical, laboratory and histological findings. In this study, we evaluated serum uromodulin as diagnostic marker for ADTKD-UMOD in a family with a novel mutation in UMOD. Methods: We investigated a family with five members suffering from chronic kidney disease of unknown origin (CKD) and three healthy members using whole exome sequencing. Serum uromodulin was measured by ELISA. The uromodulin concentration of each CKD family member was compared to reference CKD groups with similar eGFR and to non-CKD individuals in case of the healthy family members, respectively. Results: Whole exome sequencing revealed novel missense mutation c.457T>G, p.(Cys153Gly) in UMOD. Serum uromodulin concentration was lower in all affected patients compared to all patients of the reference CKD groups, while healthy family members showed normal values comparable to those of the non-CKD reference group. Conclusions: The mutation detected in our family leads to severely reduced serum uromodulin concentrations, distinguishing these patients clearly from CKD patients with comparable eGFR. Therefore, serum uromodulin could serve as a simple, new diagnostic marker to identify patients with ADTKD-UMOD. (C) 2016 The Canadian Society of Clinical Chemists.